AWS launches into Accenture and Capgemini partnerships

A couple of partnerships involving Amazon Web Services (AWS) with Accenture and Capgemini have been unveiled, around healthcare and enterprise migrations respectively.

The first partnership, announced with Accenture and Merck, aims to launch a cloud-based informatics research platform which is designed to help life sciences organisations in the early stages of drug development.

The platform will enable healthcare professionals to analyse and aggregate data from multiple applications and a single set of interfaces. The platform is being developed by Accenture and AWS with Merck being the first pharmaceutical company to use it.

Elsewhere, Capgemini and AWS are coming together to build a platform focusing on value-added cloud services for their customers, ranging from SAP migrations, to data centre modernisation and artificial intelligence (AI).

With Capgemini's partnerships with both SAP and AWS in mind, the company is able to migrate the former to the latter as part of the first focus of the initiative. The data centre modernisation will come through leveraging VMware Cloud on AWS - which regular readers of this publication will know all about - to deliver end-to-end hybrid cloud.

"Our clients look for global scale and excellence in digital transformation, enabled by cloud technologies," said Aiman Ezzat, chief operating officer at Capgemini. "With a commitment to scaling our AWS capabilities we can bring to our clients' digital jourenys both operational efficiencies and the power of new technologies, such as artificial intelligence and machine learning."

 

https://www.cybersecuritycloudexpo.com/wp-content/uploads/2018/09/cyber-security-world-series-1.pngInterested in hearing industry leaders discuss subjects like this and sharing their experiences and use-cases? Attend the Cyber Security & Cloud Expo World Series with upcoming events in Silicon Valley, London and Amsterdam to learn more.

Related Stories

Leave a comment

Alternatively

This will only be used to quickly provide signup information and will not allow us to post to your account or appear on your timeline.